Filing Details

Accession Number:
0001179110-17-002952
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-22 17:57:52
Reporting Period:
2017-02-17
Filing Date:
2017-02-22
Accepted Time:
2017-02-22 17:57:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1328034 M John Capek 100 Abbott Park Road
Abbott Park IL 60064-6400
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2017-02-17 14,273 $0.00 288,797 No 4 A Direct
Common Shares Without Par Value Acquisiton 2017-02-21 93,400 $26.70 382,197 No 4 M Direct
Common Shares Without Par Value Disposition 2017-02-21 93,400 $45.00 288,797 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Acquisiton 2017-02-17 98,714 $0.00 98,714 $44.40
Common Shares Option (right to buy) Acquisiton 2017-02-21 93,400 $0.00 93,400 $26.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
98,714 2018-02-17 2027-02-16 No 4 A Direct
0 2011-02-08 2018-02-14 No 4 M Direct
Footnotes
  1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
  2. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 32,905 on 2/17/2018, 32,904 on 2/17/2019, and 32,905 on 2/17/2020.
  3. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.